These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 16297838)

  • 1. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
    Polymenidou M; Stoeck K; Glatzel M; Vey M; Bellon A; Aguzzi A
    Lancet Neurol; 2005 Dec; 4(12):805-14. PubMed ID: 16297838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A refined method for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt-Jakob disease is not the rule.
    Notari S; Capellari S; Langeveld J; Giese A; Strammiello R; Gambetti P; Kretzschmar HA; Parchi P
    Lab Invest; 2007 Nov; 87(11):1103-12. PubMed ID: 17893675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease.
    Head MW; Northcott V; Rennison K; Ritchie D; McCardle L; Bunn TJ; McLennan NF; Ironside JW; Tullo AB; Bonshek RE
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):342-6. PubMed ID: 12506094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular typing of PrPres in human sporadic CJD brain tissue.
    Lewis V; Klug GM; Hill AF; Collins SJ
    Methods Mol Biol; 2008; 459():241-7. PubMed ID: 18576159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
    Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
    Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.
    Cali I; Miller CJ; Parisi JE; Geschwind MD; Gambetti P; Schonberger LB
    Acta Neuropathol Commun; 2015 Jun; 3():37. PubMed ID: 26108478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular classification of sporadic Creutzfeldt-Jakob disease.
    Hill AF; Joiner S; Wadsworth JD; Sidle KC; Bell JE; Budka H; Ironside JW; Collinge J
    Brain; 2003 Jun; 126(Pt 6):1333-46. PubMed ID: 12764055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
    Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
    J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody against a peptide of human prion protein discriminates between Creutzfeldt-Jacob's disease-affected and normal brain tissue.
    Curin Serbec V; Bresjanac M; Popovic M; Pretnar Hartman K; Galvani V; Rupreht R; Cernilec M; Vranac T; Hafner I; Jerala R
    J Biol Chem; 2004 Jan; 279(5):3694-8. PubMed ID: 14593100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
    Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
    Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
    Satoh K; Muramoto T; Tanaka T; Kitamoto N; Ironside JW; Nagashima K; Yamada M; Sato T; Mohri S; Kitamoto T
    J Gen Virol; 2003 Oct; 84(Pt 10):2885-2893. PubMed ID: 13679624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
    Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
    J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein.
    Xie Z; O'Rourke KI; Dong Z; Jenny AL; Langenberg JA; Belay ED; Schonberger LB; Petersen RB; Zou W; Kong Q; Gambetti P; Chen SG
    J Biol Chem; 2006 Feb; 281(7):4199-206. PubMed ID: 16338930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18383623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.